cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-088 Loxo-292

A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors

Promotor Name : Loxo Oncology, Inc.

Investigator Name : 

Trial registered on clinicaltrial.gov : NCT03899792